Catalyst4, Inc.: insider trades.
Catalyst4, Inc. reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 5 open-market purchases ($65.4M) and 0 sales, across 1 company.
- Transactions
- 5
- Purchases (P)
- 5
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Catalyst4, Inc.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | TenPercentOwner | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-14 | MapLight Therapeutics, Inc. | P | 4,400,000 | $11.38 | 25,306,689 | Form 4 |
| 2026-07-30 | MapLight Therapeutics, Inc. | P | 1,000,000 | $13 | 20,906,689 | Form 4 |
| 2026-07-29 | MapLight Therapeutics, Inc. | P | 3,000 | $12.63 | 19,906,689 | Form 4 |
| 2026-07-28 | MapLight Therapeutics, Inc. | P | 65,137 | $11.69 | 19,903,689 | Form 4 |
| 2026-07-28 | MapLight Therapeutics, Inc. | P | 141,088 | $10.74 | 19,838,552 | Form 4 |
Questions
What stock did Catalyst4, Inc. buy or sell?
Catalyst4, Inc. reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 5 open-market purchases ($65.4M) and 0 sales, across 1 company.
Is Catalyst4, Inc. the same person as other filers with this name?
This page covers SEC CIK 1900201 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/catalyst4-inc-1900201.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.